Cargando…
Successful newborn screening for Gaucher disease using fluorometric assay in China
Gaucher disease (GD) is an inherited metabolic disorder that involves accumulation of glycolipid glucocerebroside in monocyte–macrophage cells, which can result in multiple organ damage. Enzyme replacement and substrate reduction therapies have improved the potential for early diagnosis and treatmen...
Autores principales: | Kang, Lulu, Zhan, Xia, Gu, Xuefan, Zhang, Huiwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537412/ https://www.ncbi.nlm.nih.gov/pubmed/28356566 http://dx.doi.org/10.1038/jhg.2017.36 |
Ejemplares similares
-
Misinformation regarding tandem mass spectrometric vs fluorometric assays to screen newborns for LSDs
por: Millington, David S., et al.
Publicado: (2017) -
Newborn screening for Gaucher disease in Japan
por: Sawada, Takaaki, et al.
Publicado: (2022) -
Use of Ambroxol as Therapy for Gaucher Disease
por: Zhan, Xia, et al.
Publicado: (2023) -
Optimization of Fluorometric Assay for Ozone in Solution
por: Nagano, Hiromi, et al.
Publicado: (2014) -
Clinical, biochemical, and molecular genetic characteristics of patients with primary carnitine deficiency identified by newborn screening in Shanghai, China
por: Chang, Siyu, et al.
Publicado: (2022)